Susceptibility-weighted imaging for cerebral microbleed detection in super-acute ischemic stroke patients treated with intravenous thrombolysis

Neurological Research

Volumn 35, Issue 6, 2013, Pages 586-593

  Bai, Qingke ^a   Zhao, Zhenguo ^a   Sui, Haijing ^a   Xie, Xiuhai ^a   Chen, Juan ^a   Yang, Juan ^a   Zhang, Li ^a  

^a People's Hospital of Pudong District   (China)

Author keywords

Cerebral microbleeds; Ischemic stroke; Magnetic resonance imaging; Susceptibility weighted imaging; Thrombolysis

Indexed keywords

ALTEPLASE;

ADULT; AGED; ARTICLE; BARTHEL INDEX; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PROSPECTIVE STUDY; RANKIN SCALE; RECANALIZATION; RISK FACTOR; STROKE PATIENT; SUSCEPTIBILITY WEIGHTED IMAGING; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; FEMALE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84879479890     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132813Y.0000000179     Document Type: Article

References (24)

1. Feigin VL, Lawes CM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2003;2:43-53.
2. Huang YZ, McNamara JO. Ischemic stroke: 'acidotoxicity' is a perpetrator. Cell. 2004;118(6):665-6.
3. He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, et al. Major causes of death among men and women in China. N Engl J Med. 2005;353:1124-34.
4. Worp HB, Gijn JV. Acute ischemic stroke. N Engl J Med. 2007;357:572-9.
5. Wei JW, Wang JG, Huang Y, Liu M, Wu Y, Wong LKS, et al. Secondary prevention of ischemic stroke in urban China. Stroke. 2010;41:967-74.
6. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 1999;22:391-7.
7. Meretoja A, Tatlisumak T. Novel thrombolytic drugs: will they make a difference in the treatment of ischaemic stroke? CNS Drugs. 2008;22(8):619-29.
8. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-7.
9. O'Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW. 1,026 experimental treatments in acute stroke. Ann Neurol. 2006;59:467-77.
10. The NINDS t-PA Stroke Study Group. Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke. 1997;28:2119-25.
11. Hjort N, Butcher K, Davis SM, Kidwell CS, Koroshetz WJ, Röther J, et al. Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct. Stroke. 2005;36:388-97.
12. Bang OY, Saver JL, Liebeskind DS, Starkman S, Villablanca P, Salamon N, et al. Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis. Neurology. 2007;68(10):737-42.
13. Berger C, Fiorelli M, Steiner T, Schäbitz WR, Bozzao L, Bluhmki E, et al. Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke. 2001;32:1330-5.
14. Gao T, Wang Y, Zhang Z. Silent cerebral microbleeds on susceptibility-weighted imaging of patients with ischemic stroke and leukoaraiosis. Neurol Res. 2008;30:272-6.
15. Greenberg SM, Finklestein SP, Schaefer PW. Petechial hemorrhages accompanying lobar hemorrhage: detection by gradientecho MRI. Neurology. 1996;46:1751-4.
16. Stehling C, Wersching H, Kloska SP, Kirchhof P, Ring J, Nassenstein I, et al. Detection of asymptomatic cerebral microbleeds: a comparative study at 1.5 and 3.0 T. Acad Radiol. 2008;15(7):895-900.
17. Wong KS, Chan YL, Liu JY, Gao S, Lam WW. Asymptomatic microbleeds as a risk factor for aspirin-associated intracerebral hemorrhages. Neurology. 2003;60:511-3.
18. Bai Q, Zhao Z, Li Y, Sui H, Xie X, Gong Y, et al. The application of fast multiparametric protocol MRI-based thrombolysis with rt-PA hyperacute cerebral infarction. Neurol Res. 2008;30:344-7.
19. Zhao Z, Bai Q, Sui H, Xie X, Wen F. Fast multimode MRI based emergency assessment of hyperacute stroke thrombolysis. Neurol Res. 2009;31:346-50.
20. Li YH, Li MH, Zhao ZG, Bai QK. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusion, or53 h and 3-6 h. Neurol India. 2009;57:426-33.
21. Warach S, Dashe JF, Edelman RR. Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: a preliminary analysis. J Cereb Blood Flow Metab. 1996;16:53-9.
22. Hacke W, Kaste M, Bluhmki E, Brozman M, Da ́valos A, Guidetti D, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359:1317-29.
23. Arnould MC, Grandin CB, Peeters A, Cosnard G, Duprez TP. Comparison of CT and three MR sequences for detecting and categorizing early (48 hours) hemorrhagic transformation in hyperacute ischemic stroke. AJNR Am J Neuroradiol. 2004;25:939-44.
24. Donnan GA, Howells DW, Markus R, Toni D, Davis SM. Can the time window for administration of thrombolytics in stroke be increased? CNS Drugs. 2003;17:995-1011.